Ming Poi
PharmD, PhD
Assistant Professor
Pharmacy Practice and Science
152 Riffe Building


  • Cancer Therapeutics and Pharmacology
  • Clinical Pharmacokinetics & Pharmacodynamics
  • Clinical Pharmacogenetics
  • Investigational Drugs Pharmacy/Early Phase Cancer Clinical Trials

Professional Interests

The Poi Lab focuses on understanding the basis for inter-individual variation in drug disposition (pharmacokinetics, PK) and response (pharmacodynamics, PD), which include the contribution of individual genetic variations (pharmacogenetics/omics) in PK/PD. Of particular interest is the study of the CDKN2A/B (INK4-ARF) locus, which encodes three tumor suppressor genes (p14ARF, p15 and p16) in various cancers and explore potential therapeutic targets to treat cancers driven by the RB-p53-INK4-ARF tumor suppressive network.


  • 2005 – Lilly Achievement Award for achievement, leadership and professionalism
  • 2004 – Women’s Pharmacy Club Award recipient
  • 2003-2004 – Pharmacy Merit Scholarship
  • 2002-2004 – Plough Pharmacy Scholarship
  • 2002-2003 – M.C Curtin Scholarship
  • 2002-2003 – Pharmacy college Dean’s List, and Honor Roll


  • Pharmacy Fellowship in Translational Research and Clinical Investigation, 2012, The James Comprehensive Cancer Center, Columbus, Ohio
  • PGY-1 Pharmacy Practice Residency, 2010, The Ohio State University Wexner Medical Center, Columbus, Ohio
  • PharmD, 2005, The Ohio State University, Columbus, Ohio
  • PhD, 2002, (Ohio State Biochemistry Program, OSBP), The Ohio State University, Columbus, Ohio
  • BS, 1996, (molecular genetics), The Ohio State University, Columbus, Ohio

Recent Publications